The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer

被引：0
|
作者：
Sada, Yvonne [1 ]
Duan, Zhigang [1 ]
El-Serag, Hashem [1 ]
Davila, Jessica [1 ]
机构：
[1] Michael E DeBakey VA Med Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 34期
关键词：
D O I：
10.1200/jco.2012.30.34_suppl.180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
180
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Association of NCCN guideline adherence with improved survival in high-risk stage II and stage III colon cancer.
    Boland, Genevieve Marie
    Chiang, Yj
    Chagpar, Ryaz
    Xing, Yan
    Hu, Chung-Yuan
    Feig, Barry W.
    Chang, George J.
    You, Y. Nancy
    Cormier, Janice N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [12] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Kosuke Mima
    Nobutomo Miyanari
    Keisuke Kosumi
    Takuya Tajiri
    Kosuke Kanemitsu
    Toru Takematsu
    Mitsuhiro Inoue
    Takao Mizumoto
    Tatsuo Kubota
    Hideo Baba
    [J]. International Journal of Clinical Oncology, 2021, 26 : 903 - 912
  • [13] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Mima, Kosuke
    Miyanari, Nobutomo
    Kosumi, Keisuke
    Tajiri, Takuya
    Kanemitsu, Kosuke
    Takematsu, Toru
    Inoue, Mitsuhiro
    Mizumoto, Takao
    Kubota, Tatsuo
    Baba, Hideo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (05) : 903 - 912
  • [14] High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
    Zheng, Peng
    Lv, Yang
    Mao, Yihao
    Shen, Feifan
    Zhang, Zhiyuan
    Chang, Jiang
    Yu, Shanchao
    Ji, Meiling
    Feng, Qingyang
    Xu, Jianmin
    [J]. CANCERS, 2022, 14 (16)
  • [15] Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [16] Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
    Verhoeff, S. R.
    van Erning, F. N.
    Lemmens, V. E. P. P.
    de Wilt, J. H. W.
    Pruijt, J. F. M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 187 - 193
  • [17] Adjuvant Chemotherapy in High-risk Stage II Colon Cancer Patients: (Un) common Practice?
    Koebrugge, B.
    Van Steenbergen, L. N.
    Lips, D. J.
    Lemmens, V. E.
    Van der Linden, H. C.
    Pruijt, H. F.
    Liefers, G.
    Van de Velde, C. J.
    Bosscha, K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103
  • [18] Effect of a Shortened Duration of FOLFOX Chemotherapy on the Survival Rate of Patients with Stage II and III Colon Cancer
    Ji, Woong Bae
    Hong, Kwang Dae
    Kim, Jung-Sik
    Joung, Sung-Yup
    Um, Jun Won
    Min, Byung-Wook
    [J]. CHEMOTHERAPY, 2018, 63 (01) : 8 - 12
  • [19] Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
    Lee, Yujin
    Park, Inseok
    Cho, Hyunjin
    Gwak, Geumhee
    Yang, Keunho
    Bae, Byung-Noe
    [J]. ANNALS OF COLOPROCTOLOGY, 2021, 37 (05) : 298 - 305
  • [20] Duration of FOLFOX adjuvant chemotherapy in high-risk stage II and stage III colon cancer with deficient DNA mismatch repair.
    Wu, Zehua
    Hu, Huabin
    Wang, Chao
    Huang, Yan
    Deng, Yanhong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345